The 92-kDa Gelatinase B Is Expressed by Advanced Stage Melanoma Cells: Suppression by Somatic Cell Hybridization with Early Stage Melanoma Cells

Cancer Research

Volumn 55, Issue 18, 1995, Pages 4174-4181

  MacDougall, John R ^a,b,c   Bani, Maria Rosa ^a   Lin, Yulia ^a   Rak, Janusz ^a   Kerbel, Robert S ^a,b  

^a Sunnybrook Health Sciences Centre   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

^c VANDERBILT UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0029090451     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Kerbel, R. S. Growth dominance of the metastatic cancer cell:cellular and molecular aspects. Adv. Cancer Res., 55:87–132, 1990.
2. Liotta, L. A., Tryggvason, K., Garbisa, S., Hart, I., Foltz, C. M., and Shafie, S. Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature (Lond.), 284:67–68, 1980.
3. Stetler-Stevenson, W. G., Liotta, L. A., and Kleiner, D. E. Extracellular matrix 6:role of matrix metalloproteinases in tumor invasion and metastasis. FASEB J., 7; 1434–1441, 1993.
4. Nakajima, M., Welch, D. R., Belloni, P. N., and Nicolson, G. L. Degradation of basement membrane type IV collagen and lung subendothelial matrix by rat mammary adenocarcinoma cell clones of differing metastatic potentials. Cancer Res., 47:4869–4876, 1987.
5. Nakajima, M., Welch, D. R., Wynn, D. M., Tsuruo, T., and Nicolson, G. L. Serum and plasma Mt 92, 000 progelatinase levels correlate with spontaneous metastasis of rat 13762NF mammary adenocarcinoma. Cancer Res., 53:5802–5807, 1993.
6. Bernhard, E. J., Muschel, R. J., and Hughes, E. N. Mr 92, 000 gelatinase release correlates with the metastastic phenotype in transformed rat embryo cells. Cancer Res., 50:3872–3877, 1990.
7. Bernhard, E. J., Gruber, S. B., and Muschel, R. J. Direct evidence linking expression of matrix metalloproteinase 9 (92-kDa gelatinase/collagenase) to the metastatic phenotype in transformed rat embryo cells. Proc. Natl. Acad. Sci. USA, 91:4293–4297, 1994.
8. Sato, H., Kida, Y., Mai, M., Endo, Y., Sasaki, T., Tanaka, J., and Seiki, M. Expression of genes encoding type IV collagen-degrading metalloproteinases and tissue inhibitors of metalloproteinases in various human tumor cells. Oncogene, 7:77–81, 1992.
9. Librach, C. L., Werb, Z., Fitzgerald, M. L., Chiu, K., Corwin, N. M., Esteves, R. A., Grobelny, D., Galardy, R., Damsky, C. H., and Fisher, S. J. 92-kD type IV collagen-ase mediates invasion of human cytotrophoblasts. J. Cell Biol., 113:437–449, 1991.
10. Campbell, E. J., Cury, J. D., Shapiro, S. D., Goldberg, G. I., and Welgus, H. G. Neutral proteinases of human mononuclear phagocytes. J. Immunol., 146:1286–1293, 1991.
11. Watanabe, H., Nakanishi, I., Yamashita, K., Hayakawa, T., and Okada, Y. Matrix metalloproteinase-9 (92 kDa gelatinase/type IV collagenase) from U937 monoblas-toid cells:correlation with cellular invasion. J. Cell Sci., 104:991–999, 1993.
12. Bradford, M. M. A rapid and sensitive method for the quantiation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem., 72:248–254, 1976.
13. Herron, G. S., Banda, M. J., Clark, E. J., Gavrilovic, J., and Werb, Z. Secretion of metalloproteinases by stimulated capillary endothelial cells. J. Biol. Chem., 261:2814–2818, 1986.
14. Davidson, R. L. and Gerald, P. S. Improved techniques for the induction of mammalian cell hybridization by polyethylene glycol. Somatic Cell Genet., 2:165–176, 1976.
15. Onisto, M., Garbisa, S., Caenazzo, C., Freda, M. P., DiFrancesco, C., Nitti, D., Liotta, L. A., and Stetler-Stevenson, W. G. Reverse transcription-polymerase chain reaction phenotyping of metalloproteinase and inhibitors involved in tumor matrix invasion. Diagn. Mol. Pathol., 2:74–80, 1994.
16. Cornil, I., Man, S., Fernandez, B., and Kerbel, R. S. Enhanced tumorigenlcity, melanogenesis, and metastases of a human malignant melanoma after subdermal implantation in nude mice. J. Natl. Cancer Inst., 81:938–944, 1989.
17. MacDougall, J., and Kerbel, R. S. Responsiveness of normal/dysplastic melanocytes and melanoma cells from different lesional stages of disease progression to the growth inhibitory effects of TGF-0. Mol. Cell. Differ., 7:21–40, 1993.
18. Lu, C., Vickers, M. F., and Kerbel, R. S. Interleukin-6:a fibroblast-derived growth inhibitor of human melanoma cells from early but not advanced stages of tumor progression. Proc. Natl. Acad. Sci. USA, 89:9215–9219, 1992.
19. Reponen, P., Sahlberg, C., Munaut, C., Thesleff, I., and Tryggvason, K. High expression of 92 kDa type IV collagenase (gelatinase B) in the osteoclast lineage during mouse development. J. Cell Biol., 124:1091–1102, 1994.
20. de Vries, T. J., Quax, P. H. A., Denijn, M., Verrijo, K. N., Verheijen, J. H., Verspaget, H. W., and Van Muijen, G. N. P. Plasminogen activators, their inhibitors, and urokinase receptor emerge in late stages of melanocyte tumor progression. Am. J. Pathol., 144:70–81, 1994.
21. Pyke, C., Ralfkiaer, E., Tryggvason, K., and Dano, K. Messenger RNA for two type IV collagenases is located in stromal cells in human colon cancer. Am. J. Pathol., 142:359–365, 1993.
22. Basset, P., Belloq, J. P., Wolf, C., Stoll, I., Hutin, P., Limacher, J. M., Podhajcer, O. L., Chenard, M. P., Rio, M. C., and Chambon, P. A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas. Nature (Lond.), 348:699–704, 1990.
23. Poulsom, R., Pignatelli, M., Stetler-Stevenson, W. G., Liotta, L. A., Wright, P. A., Jeffery, R. E., Longcroft, J. M., Rogers, L., and Stamp, G. W. H. Stromal expression of 72 kDa type IV collagenase (MMP-2) and TIMP-2 mRNAs in colorectal neoplasia. Am. J. Pathol., 141:389–396, 1992.
24. Levy, A. T., Cioce, V., Sobel, M. E., Garbisa, S., Grigioni, W. F., Liotta, L. A., and Stetler-Stevenson, W. G. Increased expression of the Afr 72, 000 type IV collagenase in human colonic adenocarcinoma. Cancer Res., 51:439–444, 1991.
25. Stearns, M. E., and Wang, M. Type IV collagenase (A/r 72, 000) expression in human prostate:benign and malignant tissue. Cancer Res., 53:878–883, 1993.
26. Hamdy, F. C., Fadlon, E. J., Cottam, D., Lawry, J., Thurrell, W., Silcocks, P. B., Anderson, J. B., Williams, J. L., and Rees, R. C. Matrix metalloproteinase 9 expression in primary human prostatic adenocarcinoma and benign prostatic hyperplasia. Br. J. Cancer, 69:177–182, 1994.
27. Pyke, C., Ralfkiaer, E., Huhtala, P., Hurskainen, T., Dano, K., and Tryggvason, K. Localization of messenger RNA for MT 72, 000 type IV collagenases in human skin cancers by in situ hybridization. Cancer Res., 52:1336–1341, 1992.
28. Canete-Soler, R., Litzky, L., Lubensky, I., and Muschel, R. Localization of the 92 kd gelatinase mRNA in squamous cell and adenocarcinomas of the lung using in situ hybridization. Am. J. Pathol., 144:518–527, 1994.
29. Himelstein, B. P., Canete-Soler, R., Bernhard, E. J., and Muschel, R. J. Induction of fibroblast 92 kDa gelatinase/type IV collagenase expression by direct contact with metastatic tumor cells. J. Cell Sci., 107:477–486, 1994.
30. Sato, H., and Seiki, M. Rgulatory mechanism of 92 kDa type IV colagenase gene expression which is associated with invasiveness of tumor cells. Oncogene, 8:395–405, 1993.
31. Angel, P., Baumann, I., Stein, B., Delius, H., Rahmsdorf, H. J., and Herrlich, P. 12–0-tetradecanoyl-phorbol-12-acetate induction of the human collagenase gene is mediated by an inducible enhancer element located in the 5’-flanking region. Mol. Cell. Biol., 7:2256–2266, 1987.
32. Schonthal, A., Herrlich, P., Rahmsdorf, H. J., and Ponta, H. Requirement for fos gene expression in the transcriptional activation of collagenase by other oncogenes and phorbol esters. Cell, 54:325–334, 1988.
33. Conca, W., Auron, P. E., Aoun-Wathne, M., Bennett, N., Seckinger, P., Welgus, H. G., Goldring, S. R., Eisenberg, S. P., Dayer, J., Krane, S. M., and Gehrke, L. An interleukin 1/3 point mutant demonstrates that jun/fos expression is not sufficient for fibroblast metalloproteinase expression. J. Biol. Chem., 266:16265–16268, 1991.
34. Sirum-Connolly, K., and Brinckerhoff, C. E. Interleukin-1 or phorbol induction of the stromelysin promoter requires an element that cooperates with AP-1. Nucleic Acids Res., 19:335–341, 1991.
35. Auble, D. T., and Brinckerhoff, C. E. The AP-1 sequence is necessary but not sufficient for phorbol induction of collagenase in fibroblasts. Biochemistry, 30:4629–4635, 1991.
36. Osteen, K. G., Rodgers, W. H., Gaire, M., Hargrove, J. T., Gorstein, F., and Matrisian, L. M. Stromal-epithelial interaction mediates steroidal regulation of metalloproteinase expression in human endometrium. Proc. Natl. Acad. Sci. USA, 91:10129–10133, 1994.
37. Boshart, M., Nitsch, D., and Schutz, G. Extinction of gene expression in somatic cell hybrids:a reflection of important regulatory mechanisms? Trends Genet., 9:240–245, 1993.
38. Frisch, S. M., Reich, R., Collier, I. E., Genrich, L. T., Martin, G., and Goldberg, G. I. Adenovirus El A represses protease gene expression and inhibits metastasis of human tumor cells. Oncogene, 5:75–83, 1990.
39. Frisch, S. M., and Morisaki, J. H. Positive and negative transcriptional elements of the human type IV collagenase gene. Mol. Cell. Biol., 10:6524–6532, 1990.
40. Xie, B., Bucana, C. D., and Fidler, I. J. Density-dependent induction of 92 kDa type IV collagenase activity in cultures of A431 human epidermoid carcinoma cells. Am. J. Pathol., 144:1058–1067, 1994.
41. Herlyn, M., Thurin, J., Balaban, G., Bennicelli, J. L., Herlyn, D., Elder, D. E., Bondi, E., Guerry, D., Nowell, P. C., Clark, W., and Koprowski, H. Characteristics of cultured human melanocytes isolated from different stages of tumor progression. Cancer Res., 45:5670–5676, 1985.
42. MacDougall, J. R., and Kerbel, R. S. Constitutive production of 92-kDa gelatinase B can be suppressed by alterations in cell shape. Exp. Cell Res., 218:508–515, 1995.
43. Welch, D. R., Chen, P., Miele, M. E., McGary, C. T., Bower, J. M., Stanbridge, E. J., and Weissman, B. E. Microcell-mediated transfer of chromosome 6 into metastatic human C8161 melanoma cells suppresses metastasis but does not inhibit tumorige-nicity. Oncogene, 9:255–262, 1994.
44. Stoler, A. B., Stenback, F., and Balmain, A. The conversion of mouse skin squamous cell carcinomas to spindle cell carcinomas is a recessive event. J. Cell Biol., 722:1103–1117, 1993.
45. Wright, J. H., McDonnell, S., Portella, G., Bowden, G. T., Balmain, A., and Matrisian, L. M. A switch from stromal to tumor cell expression of stromelysin-1 mRNA associated with the conversion of squamous to spindle carcinomas during mouse skin tumor progression. Mol. Carcinog., 10:207–215, 1994.
46. Lehmann, J. M., Riethmuller, G., and Johnson, J. P. MUC18, a marker of tumor progression in human melanoma shows sequence similarity to the neural cell adhesion molecules of the immunoglobulin superfamily. Proc. Natl. Acad. Sci. USA, 330:9891–9895, 1989.
47. Johnson, J. P., Stade, B. G., Holzmann, B., Schwable, N., and Reithmuller, G. De novo expression of intercellular adhesion molecule 1 in melanoma correlates with increased risk of metastasis. Proc. Natl. Acad. Sci. USA, 86:641–644, 1989.
48. Albelda, S. M., Mette, S. A., Elder, D. E., Stewart, R., Damjanovich, L., Herlyn, M., and Buck, C. A. Integrin distribution in malignant melanoma:Association of the 03 subunit with tumor progression. Cancer Res., 50:6757–6764, 1990.
49. Herlyn, M., Graeven, U., Speicher, D., Sela, B.-A., Bennicelli, J.L., Kath, R., and Guerry, D. Characterization of tenascin secreted by human melanoma cells. Cancer Res., 57:4853–4858, 1991.
50. Lu, C., and Kerbel, R. S. Interleukin-6 undergoes transition from paracrine growth inhibitor to autocrine stimulator during human melanoma progression. J. Cell Biol., 720:1281–1288, 1993.
51. Turpeeniemi-Huganen, T., Thorgeirsson, U. P., Hart, I. R., Grant, S. S., and Liotta, L. A. Expression of collagenase IV (basement membrane collagenase) activity in murine tumor cell hybrids that differ in metastatic potential. J. Natl. Cancer Inst., 75:99–103, 1985.
52. Reich, R., Thompson, E. W., Iwamato, Y., Martin, G. R., Deason, J. R., Fuller, G. C., and Miskin, R. Effects of inhibitors of plasminogen activator, serine proteinases, and collagenase IV on the invasion of basement membranes by metastatic cells. Cancer Res., 48:3307–3312, 1988.